Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0657127B2 - Health food mainly composed of cultured mycelium of Kawariharatake or its extract - Google Patents
[go: Go Back, main page]

JPH0657127B2 - Health food mainly composed of cultured mycelium of Kawariharatake or its extract - Google Patents

Health food mainly composed of cultured mycelium of Kawariharatake or its extract

Info

Publication number
JPH0657127B2
JPH0657127B2 JP3162489A JP3162489A JPH0657127B2 JP H0657127 B2 JPH0657127 B2 JP H0657127B2 JP 3162489 A JP3162489 A JP 3162489A JP 3162489 A JP3162489 A JP 3162489A JP H0657127 B2 JPH0657127 B2 JP H0657127B2
Authority
JP
Japan
Prior art keywords
kawariharatake
mycelium
extract
health food
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP3162489A
Other languages
Japanese (ja)
Other versions
JPH02211847A (en
Inventor
利光 隅谷
均 伊藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP3162489A priority Critical patent/JPH0657127B2/en
Publication of JPH02211847A publication Critical patent/JPH02211847A/en
Publication of JPH0657127B2 publication Critical patent/JPH0657127B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Confectionery (AREA)
  • Alcoholic Beverages (AREA)
  • Preparation Of Fruits And Vegetables (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Description

【発明の詳細な説明】 <産業上の利用分野> 本発明はカワリハラタケの培養菌糸体の乾燥品、又はそ
の水性溶媒抽出液を利用する健康食品に関する。
DETAILED DESCRIPTION OF THE INVENTION <Industrial field of application> The present invention relates to a dry product of cultured mycelium of Kawariharatake or a health food using an aqueous solvent extract thereof.

<従来の技術> 本発明において用いられるカワリハラタケは本発明者が
はじめて人工培養に成功したものであり、その培養方法
の一部は特公昭61−47519号(「抗腫瘍作用を有する蛋
白多糖体の製造方法」)(特許第1442648号)に記載さ
れている。カワリハラタケ(通称ヒロマツタケ)はハラ
タケ科ハラタケ属に属し、学名は「Agaricus blazei Mu
rrill」である。その担子菌は、ブラジル国サンパウロ
州ピエダーテ市郊外で採取されたもので、既に工業技術
院微生物工業技術研究所に微工研菌寄第4731号として寄
託されている。
<Prior Art> The agaricus mushroom used in the present invention is the one that the present inventor succeeded in artificial culture for the first time, and a part of the culture method is disclosed in Japanese Patent Publication No. 61-47519 (“Protein polysaccharide having an antitumor activity. Manufacturing method ") (Patent No. 1442648). Kawariharatake (commonly known as hiromatsutake) belongs to the genus Agaricaceae, and the scientific name is "Agaricus blazei Mu.
rrill ”. The basidiomycete was collected in the suburbs of Piedate City, Sao Paulo State, Brazil, and has already been deposited at the Institute of Microbial Science and Technology, Industrial Technology Institute as Micromachine Research Institute No. 4731.

カワリハラタケ由来の高分子多糖体の抗腫瘍作用につい
ては昭和55年3月、第53回日本薬理学会総会におい
て発表して以来、現在まで次のように多くの報告を行っ
てきた。
The antitumor effect of Kawariharatake-derived high molecular weight polysaccharides has been reported as many as follows since it was announced at the 53rd Annual Meeting of the Japanese Pharmacological Society in March 1980.

伊藤 均:第39回日本癌学会総会記事,:350頁,198
0年, 伊藤 均他:Japan J.Pharmacol.,:31(Suppl:170
頁,1981年, 伊藤 均他:感染症:14巻No.1,18頁,1984年, 伊藤 均他:Japan J.Pharmacol.,33(suppl)149頁,1
983年, 伊藤 均他:Japan J.Pharmacol.,:33巻,403頁,19
83年, 伊藤 均他:第43回日本癌学会総会記事,:279頁,1
984年, 伊藤 均他:医学と生物学,:109巻No.5,299頁,198
4年, 伊藤 均他:第10回糖質シンポジウム講演要旨集,:
B3,1987年,) これらの報告の中で、カワリハラタケの子実体、菌糸
体、菌糸体の培養濾液画分に抗腫瘍性の多糖体成分(蛋
白多糖体)が含まれることを明らかにしてきた。多糖体
成分の抗腫瘍性はすべて動物の腹腔内投与の成績にもと
づくものである。
Hitoshi Ito: The 39th Annual Meeting of the Japanese Cancer Association, 350 pages, 198
0 years, Hitoshi Ito et al .: Japan J. Pharmacol.,: 31 (Suppl: 170
Page, 1981, Hitoshi Ito et al .: Infectious diseases: Volume 14, No. 1, 18 pages, 1984, Hitoshi Ito et al .: Japan J. Pharmacol., 33 (suppl) 149, 1
983, Hitoshi Ito et al .: Japan J. Pharmacol., 33: 403, 403, 19
1983, Hitoshi Ito et al .: The 43rd Annual Meeting of the Japanese Cancer Society, pp. 279, 1
984, Hitoshi Ito et al .: Medicine and Biology, Volume 109, No. 5, 299, 198
4th, Hitoshi Ito et al .: Proceedings of the 10th Glycosymposium Symposium ,:
B3, 1987,) In these reports, it has been clarified that fruiting bodies, mycelia, and culture filtrate fractions of Mycelium agaricus contain an antitumor polysaccharide component (protein polysaccharide). . The antitumor properties of the polysaccharide components are all based on the results of intraperitoneal administration in animals.

一連の研究で、カワリハラタケから得られる多糖体成分
が人体の免疫活性を賦活する作用を有し、固体腫瘍をは
じめ他のキノコ類では効果のない腹水型腫瘍にも薬効を
示すことが判明した。
In a series of studies, it was found that the polysaccharide component obtained from Kawariharatake has a function of activating the immune activity of the human body and has a medicinal effect on ascites tumors which are ineffective against other mushrooms such as solid tumors.

カワリハラタケの子実体、菌糸体、培養濾液からの抗腫
瘍性蛋白多糖体の製造に関しては、既に特許出願してお
り、公表されている(特開昭55−74797号、特開昭55-10
8292号、特開昭55-108293号参照。)。
Regarding the production of antitumor protein polysaccharides from fruiting bodies, mycelium, and culture filtrate of Kawariharatake, a patent application has already been filed and published (JP-A-55-74797, JP-A-55-10).
See 8292 and JP-A-55-108293. ).

キノコは古くから食用として利用されてきたが、最近の
研究でキノコに含まれる成分の薬理活性が明らかにな
り、医薬品として用いられているものもある。また、キ
ノコは漢方で薬効が認められているものも多いことか
ら、その優れた薬効を期待してキノコの子実体、その抽
出物等を体内に容易に摂取できる食品素材として利用す
る試みも色々なされている。
Mushrooms have been used for food since ancient times, but recent studies have revealed the pharmacological activity of the components contained in mushrooms, and some have been used as pharmaceuticals. In addition, since many of the mushrooms are known to have medicinal effects in Chinese herbs, various attempts have been made to utilize the fruiting bodies of mushrooms and their extracts as food materials that can be easily ingested into the body in anticipation of their superior medicinal effects. Has been done.

例えば、マンネンタケは子実体、またはその抽出物を健
康食品の原料として用いることが報告されている(特公
昭58−36946号)。
For example, Ganoderma lucidum has been reported to use fruiting bodies or extracts thereof as raw materials for health foods (Japanese Patent Publication No. 58-36946).

また、キノコ種菌を培養して得られる菌糸体の乾燥物を
用いて食品を製造することも知られている(特開昭54−
11250号、特開昭51−125788号、特公昭58−15108号)。
It is also known to produce a food using a dried product of a mycelium obtained by culturing a mushroom inoculum (JP-A-54-54).
11250, JP-A-51-125788, JP-B-58-15108).

抗腫瘍性が期待されるキノコ利用食品の製造においては
グルカン,グルカンタンパクを含む子実体またはその抽
出物が食品原料として用いられている。カワリハラタケ
の子実体にもグルカン、グルカンタンパクが含まれてお
り、子実体又はその抽出物を用いて健康食品を製造する
試みがなされている(特開昭60−69026号)。
Glucan, fruiting bodies containing glucan proteins or extracts thereof are used as food materials in the production of mushroom-based foods that are expected to have antitumor properties. The fruiting body of Kawariharatake also contains glucan and glucan protein, and an attempt has been made to produce a health food using the fruiting body or an extract thereof (JP-A-60-69026).

健康食品と呼ばれているものは伝承等により健康増進、
病気予防と効果を有するものと期待され、通常の食生活
においても広く利用されているが、人体への効果が明確
に確認されている例は余りない。キノコに関しても薬理
活性成分の研究は進んでいるが、多糖体成分の経口投与
による抗腫瘍効果が明確に確認できたとする報告は今ま
でのところ見当らない。
What is called health food promotes health through tradition, etc.
It is expected to have disease prevention and effects, and is widely used in ordinary dietary habits, but there are few examples where the effects on the human body have been clearly confirmed. Although studies on pharmacologically active components of mushrooms are in progress, no reports have been found so far that the antitumor effect of oral administration of polysaccharide components was clearly confirmed.

また、カワリハラタケの培養菌糸体から得られるマンナ
ン蛋白多糖体が経口投与で有効であることを科学的に証
明した研究報告もない。このマンナン蛋白多糖体はマン
ノースが重合した高分子多糖に蛋白分子が結合した構造
のもので、カワリハラタケの菌糸体と菌糸体培養濾液に
含まれる特殊な蛋白多糖体である。この多糖体がカワリ
ハラタケの子実体から分離されたという報告はなく、こ
れと同じものが他のキノコから得られたという報告も今
までのところない。カワリハラタケ培養菌糸体中のマン
ナン蛋白多糖体が、抗腫瘍作用が今までに知られている
グルカン、グルカンタンパクと成分的に異なることはこ
れまでの研究から明らかになってきたが、マンナン蛋白
多糖体の抗腫瘍性に関する研究はまだ基礎的な段階にあ
る。
Further, there is no research report scientifically demonstrating that the mannan protein polysaccharide obtained from cultured mycelium of Kawariharatake is effective by oral administration. This mannan protein polysaccharide has a structure in which a protein molecule is bound to a polymeric polysaccharide obtained by polymerizing mannose, and is a special protein polysaccharide contained in the mycelium of Kawariharatake and the mycelium culture filtrate. There is no report that this polysaccharide was separated from the fruiting body of Kawariharatake, and there has been no report so far that the same was obtained from other mushrooms. It has been clarified from previous studies that mannan protein polysaccharide in cultured mycelium of Kawariharatake is different in composition from glucan and glucan protein, which have been known so far, but it has been revealed from the previous studies. The research on the antitumor properties of is still in the basic stage.

上記したようにカワリハラタケ菌糸体はマンナン蛋白多
糖体を含んでいるがこの菌糸体又はその抽出液を食品の
原料として利用したという報告もない。
As described above, the agaric mycelium contains the mannan protein polysaccharide, but there is no report that this mycelium or its extract was used as a raw material for food.

<本発明が解決しようとする課題> 生理活性機能を有する成分が食品として利用されるため
にはそれが、経口投与で消化管からよく吸収され、長期
間多量に摂取しても人体に悪影響を及ぼさないことが必
要不可欠である。
<Problems to be Solved by the Present Invention> In order for a component having a physiologically active function to be utilized as a food, it is well absorbed from the digestive tract by oral administration and adversely affects the human body even if ingested in large amounts for a long period of time. It is indispensable not to reach.

抗腫瘍性を有す多糖体の中からこのような条件を満たす
ものが見出されれば、家庭で手軽に摂取でるので利用範
囲が広がり、多くの人々の健康増進に役立つものと期待
される。
If polysaccharides having antitumor properties that meet these conditions are found, they can be easily taken at home and the range of use is expanded, which is expected to be useful for the health promotion of many people.

しかしながら、高分子多糖体は消化管から吸収されない
と一般には推定されていたので、キノコから得られる高
分子多糖に対して経口投与により抗腫瘍性を確認すると
いう研究は殆ど行われていない。
However, since it has been generally estimated that high molecular weight polysaccharides are not absorbed from the digestive tract, almost no studies have been conducted to confirm the antitumor properties of high molecular weight polysaccharides obtained from mushrooms by oral administration.

本発明はカワリハラタケの培養菌糸体に含まれるマンナ
ン蛋白多糖体を含有し、経口的に摂取した場合に抗腫瘍
効果が認められる健康食品を提供することを目的として
いる。
An object of the present invention is to provide a health food containing a mannan protein polysaccharide contained in cultured mycelium of Kawariharatake and having an antitumor effect when orally ingested.

<課題を解決するための手段> 本発明者は、マンナン蛋白多糖体成分の抗腫瘍作用につ
いて鋭意研究を重ねた結果、意外にもマンナン蛋白多糖
体が動物実験における経口投与においてもサルコーマ18
0型腫瘍やエーリッヒ腹水型腫瘍に対し抗腫瘍活性を有
することを見出した。
<Means for Solving the Problems> As a result of earnest studies on the antitumor effect of the mannan protein polysaccharide component, the present inventor has surprisingly found that the mannan protein polysaccharide is sarcoma 18 even in oral administration in animal experiments.
It was found to have antitumor activity against type 0 tumor and Ehrlich ascites tumor.

また、このマンナン蛋白多糖体は可及的に投与できる最
大経口投与量においても急性毒性(50%致死量3000mg/k
g以上)は全く発現せず、副作用、安全性の面でも優れ
ていること、そして、このような多糖体を含む培養菌糸
体が食料原料として適していることが判明し、これらの
知見に基づき本発明を完成した。
In addition, this mannan protein polysaccharide has acute toxicity (50% lethal dose 3000 mg / k) even at the maximum oral dose that can be administered.
g or more) is not expressed at all, it is excellent in terms of side effects and safety, and that the cultured mycelium containing such a polysaccharide is suitable as a food material. Based on these findings, The present invention has been completed.

すなわち、本発明はマンナン蛋白多糖体を含む培養菌糸
体の乾燥品、又はその水性溶媒抽出液を含有する健康食
品及び、水性溶媒抽出液の濃縮液を含有する健康食品を
提供するものである。
That is, the present invention provides a dried product of cultured mycelium containing mannan protein polysaccharide, or a health food containing the aqueous solvent extract thereof, and a health food containing a concentrated solution of the aqueous solvent extract.

本発明で用いる培養菌糸体はカワリハラタケ菌の培養物
から分離されるものである。培養菌糸体の水性溶媒抽出
液は培養菌糸体を一旦乾燥した後水性溶媒で抽出したも
のである。
The cultured mycelium used in the present invention is isolated from the culture of Kawariharatake. The aqueous solvent extract of the cultured mycelium is obtained by once drying the cultured mycelium and then extracting it with an aqueous solvent.

カワリハラタケの培養菌糸体は乾燥し8%以下の水分含
量にして一般には利用される。この製品状態は軽量化が
達成できるほか細菌の繁殖、変敗の防止に対しても好条
件であり、保存上、流通上最適の商品形態とされてい
る。
Cultured mycelium of Kawariharatake is dried and generally used with a water content of 8% or less. This product state is a condition that is not only lightweight but also good for bacterial growth and prevention of spoilage, and is considered to be the most suitable product form for storage and distribution.

乾燥品は小片状に切断、あるいは粉末化して用いられ
る。これらはペースト、ふりかけなどの製造において食
品原料として使用できる。
The dried product is cut into small pieces or powdered before use. These can be used as a food material in the production of pastes, sprinkles and the like.

さらに、乾燥品を切断あるいは粉末化したものはそのま
ま紙袋に充填包装し、紅茶のティーバックのように商品
化し、消費者自からの手で容易に成分を抽出して飲料に
用いることも可能である。
It is also possible to cut and powder the dried product and pack it in a paper bag as it is, commercialize it like a tea bag of black tea, and easily extract the ingredients with the hands of the consumer and use it for beverages. is there.

また、カワリハラタケ培養後の菌糸体は美味で栄養的で
あるので、シイタケのように、例えば多少の調味料を加
えるだけで食品となる。
Moreover, since the mycelium after culturing Kawariharatake is delicious and nutritious, it can be made into a food by adding a little seasoning, such as shiitake mushroom.

カワリハラタケの培養菌糸体成分を一旦水性溶媒で抽出
し得られる抽出液そのもの又はその濃縮液を食品原料と
し健康食品を製造することもできる。水性溶媒抽出液を
そのまま、あるいは濃縮して食用に供することは、原料
本来の品質を損なうことのない合理的利用方法である。
It is also possible to produce a health food by using the extract itself obtained by once extracting the cultured mycelium component of Kawariharatake with an aqueous solvent or a concentrated solution thereof as a food material. It is a rational use method that does not impair the original quality of the raw material, and that the aqueous solvent extract is used as it is or after being concentrated for use in food.

水性溶媒として水、アルコール、その混合物のいずれで
もよい。
The aqueous solvent may be water, alcohol or a mixture thereof.

一般に、動物試験によればキノコ自体に含まれる蛋白多
糖体は精製を重ねるほど抗腫瘍効果が低下することが認
められているので、医薬品に使用する場合と異なり、精
製を重ねずに使用する方が、キノコの蛋白多糖体成分を
有効に利用できるものである。
In general, animal tests have shown that the protein polysaccharide contained in the mushroom itself has a lower antitumor effect as it is further purified. However, the protein polysaccharide component of mushrooms can be effectively used.

なお、カワリハラタケ培養菌糸体の水性溶媒抽出液など
から抗腫瘍性有効成分の主体であるマンナン蛋白多糖体
を採取する方法については、特公昭61−47518号(特許
第1442647号)に開示している。
Incidentally, a method for collecting mannan protein polysaccharide, which is the main component of the antitumor active ingredient, from an aqueous solvent extract of agaricus agaricus culture mycelium, etc. is disclosed in Japanese Examined Patent Publication No. 61-47518 (Patent No. 1442647). .

カワリハラタケ培養菌糸体の乾燥品を水性溶媒で抽出し
て得られる液はそのまま飲料として利用できるが、これ
に他の食品原料を加えて飲料とすることもできる。抽出
液の利用により、例えばアルコール飲料、茶、カワリハ
ラタケ飲料などが製造できる。カワリハラタケの培養菌
糸体成分(マンナン蛋白多糖体)の水性抽出液は、その
まま飲料として利用するばかりでなく、食料加工原料に
添加して加工食品の形の健康食品として製造することも
可能である。たとえばブイヨンに添加混合してスープを
製造したり、水飴などに混入して飴を製造したり、…な
ど種々のものが考えられ、何れも抗腫瘍作用を有する健
康食品として価値の高い食品が得られる。
The liquid obtained by extracting the dried mycelium of Kawariharatake mycelium with an aqueous solvent can be used as a beverage as it is, but other food materials can be added to this to make a beverage. By using the extract, for example, alcoholic beverages, tea, agaricus beverages, etc. can be produced. The aqueous extract of cultured mycelium component (mannan protein polysaccharide) of Kawariharatake can be used not only as a beverage as it is, but also as a health food in the form of a processed food by adding it to a food processing raw material. For example, a variety of things can be considered, such as adding and mixing with broth to produce soup, mixing with starch syrup to produce candy, etc., all of which yield foods with high value as health foods with antitumor activity. To be

以上の種々の食品としての利用にあたって、摂食ないし
飲用量は、1回あたり、カワリハラタケの培養菌糸体か
ら得られる蛋白多糖体の乾燥品としての量で7〜10gが
抗腫瘍効果を発揮する適当量であり、抽出液量について
もこの相当量が適当とみられる。なおこれ以上に過剰に
摂取したとしても、それによって与えられる障害は全く
ない。
In the use as various foods as described above, the amount of the protein or polysaccharide obtained from the cultured mycelium of Kawariharatake is 7 to 10 g as a dry product per dose, which is suitable for exerting an antitumor effect. It is the amount, and it is considered that this equivalent amount is suitable for the amount of the extract. Even if it is taken more than this, there is no damage caused by it.

実施例−1カワリハラタケつくだに 調味液として水1.8リットル、寒天24g、醤油6.3リット
ル、水飴17kg、砂糖2.25kgを煮てとかしておく。原料の
カワリハラタケ培養菌糸体乾燥品に少量の砂糖を加えた
水でもどし、これに調味液を加えて焦げつかないように
煮汁がなくなるまで煮る。
Example-1 Kawariharatake Tsukudani As a seasoning liquid, 1.8 liters of water, 24 g of agar, 6.3 liters of soy sauce, 17 kg of starch syrup, and 2.25 kg of sugar are boiled and melted. Dry the dried mycelium of Kawariharatake, the raw material, with water containing a small amount of sugar, add the seasoning solution to it, and boil until the broth is gone without burning.

実施例−2カワリハラタケふりかけ 醤油8リットルにグルタミン酸ソーダ100g、砂糖1kgを
煮とかした調味液をつくる。カワリハラタケ培養菌糸体
乾燥品粉末、あるいは場合によってはこれにアジなどの
魚肉粉末を加えたものを煮釜に入れ、前記調味液を適当
量加えて約40分間調味煮熟する。これを篩い機にかけて
粒子をそろえた上で乾燥機にかけ、80℃で2時間乾燥す
る。必要に応じて、これにコンブ、青のり、ゴマなども
加えて防湿包装する。
Example-2 Sprinkling Kawariharatake 8 g of soy sauce, 100 g of sodium glutamate and 1 kg of sugar are boiled to prepare a seasoning liquid. Kawariharatake cultured mycelium dried product powder or, if necessary, fish meat powder such as horse mackerel is added to a kettle, and the seasoning solution is added in an appropriate amount to ripen and season for about 40 minutes. This is passed through a sieving machine to align the particles, and then dried, followed by drying at 80 ° C. for 2 hours. If necessary, add kelp, green seaweed, sesame seeds, etc., and package in a moisture-proof manner.

実施例−3カワリハラタケ茶 カワリハラタケ培養菌糸体乾燥品粉末を不織布で作った
小袋に封入し防湿包装する。袋中のカワリハラタケ培養
菌糸体乾燥品粉末量の飲用量は1日7〜10gが適当であ
る。飲用時にはこの袋1ケを鍋に水約400mlと共に入
れ、吹きこぼれないように時々水を加えながら加熱抽出
15分後、冷却、抽出液全量を300mlくらいにする。これ
を1日2〜3日にわけて飲用する。飲用時、少量の食塩
を加えると更に美味になる。
Example-3 Kawariharatake tea Kawariharatake cultured mycelium dried product powder is enclosed in a small bag made of non-woven fabric and moisture-proof packed. The appropriate amount of the dried agaricus mycelium dried product powder amount in the bag is 7 to 10 g per day. When drinking, put this bag in a pan with about 400 ml of water, and heat extraction while adding water occasionally to prevent spilling.
After 15 minutes, cool and bring the total volume of the extract to about 300 ml. This is divided into 2 to 3 days for drinking. When drinking, add a small amount of salt to make it even more delicious.

実施例−4カワリハラタケ飲料 カワリハラタケ培養菌糸体乾燥品粉末1kgに水約40kgを
加え、十分吸水させてから2〜3時間、時々水を補給し
ながら加熱後、適宜濾過する。粉末を使えば加熱時間を
短縮して同様に操作できる。全抽出液をほぼ30kg程度に
なるようにする。これを熱水抽出液とする。
Example-4 Kawariharatake Drink About 40 kg of water was added to 1 kg of dried dried mycelium of Kawariharatake, and after adequately absorbing water, the mixture was heated for 2 to 3 hours with occasional water replenishment, and then appropriately filtered. If powder is used, the heating time can be shortened and the same operation can be performed. Adjust the total extract to approximately 30 kg. This is a hot water extract.

次に、この熱水抽出液1kgに対し、たとえば糖類140g、
蜂蜜15g、カラメル5g、アスコルビン酸0.75g、クエン
酸0.3g、香料適量を加え、93℃で20分殺菌し、無菌的に
缶またはびんに充填する。なお、上記配合には他の健康
性抽出物、たとえば霊芝、アマチャ・ヅルなどの抽出物
を適宜添加することを妨げるものではない。
Next, for 1 kg of this hot water extract, for example, 140 g of sugar,
Add 15 g of honey, 5 g of caramel, 0.75 g of ascorbic acid, 0.3 g of citric acid and an appropriate amount of fragrance, sterilize at 93 ° C for 20 minutes, and aseptically fill a can or bottle. It should be noted that it does not prevent the addition of other health extracts, such as Reishi, Amacha vine, etc., to the above formulation.

実施例−5カワリハラタケ酒 カワリハラタケ培養菌糸体乾燥品を適宜に粗に刻んだも
の1kgに対して、好みにより氷砂糖5〜10kgを加え、焼
酎またはホワイトリカー18リットルを静かに注入して密
封、貯蔵する。
Example-5 Kawariharatake liquor 1-5 kg of dried dried mycelium of Kawariharatake is appropriately added to 5 kg of ice sugar, and 18 liters of shochu or white liquor is gently injected to seal and store.

3〜4週間経過後、濾過し、びん詰とする。1回30〜50
mlを飲用する。
After 3 to 4 weeks, filter and bottle. 30 to 50 times
Take ml.

実施例−6カワリハラタケ飴 砂糖50kgに実施例4に示したカワリハラタケ培養菌糸体
乾燥品粉末25kgを加えて完全に煮とかし、さらに水飴7.
5kgを加えて煮つめる。冷水中に滴下して固まる程度に
なったら、火からおろし、必要に応じて色素、香料、酸
味料などを加える。これを油をひいた冷却盤またはタブ
レット桟にかけて冷却整型する。
Example-6 Kawariharatake candy 25 kg of dried Kawariharatake mycelium powder of dried mycelium shown in Example 4 was added to 50 kg of sugar, and the mixture was completely boiled and further starch syrup 7.
Add 5 kg and boil. When it drips into cold water until it hardens, remove from heat and add dyes, flavors, acidulants, etc. as needed. This is cooled and shaped by placing it on an oiled cooling board or tablet rail.

なお、カワリハラタケ培養菌糸体熱水抽出液を使用する
かわりに、その濃縮物、あるいは粉末を水に懸濁させて
加えることも可能である。
Instead of using the hot water extract of cultured mycelium of Kawariharatake, its concentrate or powder may be suspended in water and added.

<発明の効果> カワリハラタケの菌糸体に含まれるマンナン蛋白多糖体
は経口投与によっても抗腫瘍効果が認められるという大
きな長所がある。またこのマンナン蛋白多糖体は常用し
ても人体に悪影響を及ぼさないことも明らかになった。
<Effects of the Invention> The mannan protein polysaccharide contained in the mycelium of Kawariharatake has a great advantage that an antitumor effect is observed even when it is orally administered. It was also revealed that this mannan protein polysaccharide does not adversely affect the human body even if it is used regularly.

従って、マンナン蛋白多糖体を多量に含むカワリハラタ
ケの培養菌糸体及びその水性抽出物を含む食品は抗腫瘍
作用及び効果を有する優れた健康食品である。
Therefore, the food containing the cultured mycelium of Kawariharatake and the aqueous extract thereof containing a large amount of mannan protein polysaccharide is an excellent health food having an antitumor action and effect.

この抗腫瘍効果の動物実験の結果について述べると、 ICR/SLC系(5周令雌マウス:日本エスエルシー株式会
社(静岡))を各群とも12匹使用、 マウスの皮下に2×10個/0.2ml,サルコーマ180腫
瘍細胞を移植し、腫瘍移植24時間後より各検体を1日
2回、朝(午前9時)夕(午後5時)10日間連日投与
を行った。
The results of this antitumor effect in animal experiments are as follows: 12 ICR / SLC strains (five-week-old female mice: Japan SLC, Inc. (Shizuoka)) were used, and 2 × 10 6 mice were subcutaneously injected. /0.2 ml, sarcoma 180 tumor cells were transplanted, and 24 hours after the tumor transplantation, each sample was administered twice a day for 10 consecutive days in the morning (9 am) and evening (5 pm).

腫瘍移植後3週間後に腫瘍体積を測定し増殖抑制率を算
出した。
The tumor volume was measured 3 weeks after the tumor transplantation, and the growth inhibition rate was calculated.

また、腫瘍の完全消失率と死亡率は8週間後に測定し
た。
The complete disappearance rate and mortality rate of the tumor were measured after 8 weeks.

測定結果は次の表に示す通りであった。The measurement results were as shown in the following table.

また、これらは常用しても人体に悪影響を及ぼさないこ
とも明らかになった。
It was also clarified that these do not have any adverse effects on the human body even if they are used regularly.

従って、上記した培養菌糸体またはその水性溶媒抽出液
を食品原料に加えることにより抗腫瘍作用を有する食品
を得ることができる。
Therefore, a food having an antitumor effect can be obtained by adding the above-mentioned cultured mycelium or its aqueous solvent extract to a food material.

マンナン蛋白多糖体は食品として用いる場合は精製する
必要がないので、そのための設備も不要であり、マンナ
ン蛋白多糖体を含む健康食品は容易に製造できるという
利点がある。
Since the mannan protein polysaccharide does not need to be purified when used as a food, there is no need for equipment therefor, and there is an advantage that a health food containing the mannan protein polysaccharide can be easily produced.

また、マンナン蛋白多糖体は食品としての利用であるの
で医薬品の扱いを受けず、家庭でも手軽に利用できると
いう効果もある。
Further, since the mannan protein polysaccharide is used as a food, it has an effect that it can be easily used at home without being treated as a medicine.

更に、本願発明ではカワリハラタケの培養菌糸体は乾燥
物として用いるので取扱いが容易であるだけでなく、保
存上も有利であるという効果もある。
Further, in the present invention, since the cultured mycelium of Kawariharatake is used as a dried product, it is not only easy to handle but also advantageous in storage.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 C12G 3/04 // A61K 35/84 Z 7167−4C (56)参考文献 特開 昭60−69026(JP,A) 特開 昭51−125788(JP,A) 特開 昭54−11250(JP,A) 特公 昭58−15108(JP,B2) 藤沢薬品工業「感染症」14[1 ](1984.1月)P.18−19─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI technical display location C12G 3/04 // A61K 35/84 Z 7167-4C (56) Reference JP-A-60-69026 (JP, A) JP 51-125788 (JP, A) JP 54-11250 (JP, A) JP 58-15108 (JP, B2) Fujisawa Yakuhin Kogyo "Infectious Disease" 14 [1] ( 1984. January) P. 18-19

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】カワリハラタケの培養菌糸体の乾燥品を小
片状に切断あるいは細粉化したものを含有する健康食
品。
1. A health food containing a dried mycelium of Kawariharatake mushrooms cut into small pieces or pulverized.
【請求項2】カワリハラタケの培養菌糸体の乾燥品を水
性溶媒で抽出して得られる抽出液を含有する健康食品。
2. A health food containing an extract obtained by extracting a dried product of cultured mycelium of Kawariharatake with an aqueous solvent.
【請求項3】カワリハラタケの培養菌糸体の乾燥品を水
性溶媒で抽出し、それを濃縮して得られる濃縮液を含有
する健康食品。
3. A health food containing a concentrated solution obtained by extracting a dried product of cultured mycelium of Kawariharatake with an aqueous solvent and concentrating it.
JP3162489A 1989-02-10 1989-02-10 Health food mainly composed of cultured mycelium of Kawariharatake or its extract Expired - Lifetime JPH0657127B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3162489A JPH0657127B2 (en) 1989-02-10 1989-02-10 Health food mainly composed of cultured mycelium of Kawariharatake or its extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3162489A JPH0657127B2 (en) 1989-02-10 1989-02-10 Health food mainly composed of cultured mycelium of Kawariharatake or its extract

Publications (2)

Publication Number Publication Date
JPH02211847A JPH02211847A (en) 1990-08-23
JPH0657127B2 true JPH0657127B2 (en) 1994-08-03

Family

ID=12336373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3162489A Expired - Lifetime JPH0657127B2 (en) 1989-02-10 1989-02-10 Health food mainly composed of cultured mycelium of Kawariharatake or its extract

Country Status (1)

Country Link
JP (1) JPH0657127B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2777073B2 (en) * 1994-12-02 1998-07-16 有限会社荻田バイオ・サイエンス研究所 Low-temperature extraction method of Ganoderma lucidum extract
JP3051073B2 (en) * 1996-12-20 2000-06-12 住友林業株式会社 Antitumor active substance
JP3830649B2 (en) * 1998-01-16 2006-10-04 株式会社 山王アガリクス研究所 Protein polysaccharide 0041
KR100762848B1 (en) * 2006-05-25 2007-10-04 씨제이 주식회사 Method for producing fungal protein, fungal protein produced thereby, low-calorie artificial and natural meat flavoring agent containing the fungal protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125788A (en) * 1975-03-06 1976-11-02 Nakada Kunii Method for cultivating and processing of mashrooms
JPS5411250A (en) * 1977-06-10 1979-01-27 Japan Synthetic Rubber Co Ltd Production of powdery food
JPS5815108A (en) * 1981-07-20 1983-01-28 Mitsubishi Heavy Ind Ltd Measuring device for position of assembled piping
JPS6069026A (en) * 1983-09-27 1985-04-19 Nichijiyou:Kk Health food containing antitumor components from "himematsutake"

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
藤沢薬品工業「感染症」14[1(1984.1月)P.18−19

Also Published As

Publication number Publication date
JPH02211847A (en) 1990-08-23

Similar Documents

Publication Publication Date Title
CN102242070B (en) Method for artificially culturing paecilomyces cicadae and application of culturing product thereof
CN102285826A (en) Liquid culture medium for Dictyophora rubrovalvata liquid fermentation
JP2004307453A (en) Vascularization inhibitor and use thereof
KR101806720B1 (en) Antibacterial-listeria composition of culture medium containing membranous milkvetch root fermented with lactobacillus plantarum
JP2002065206A (en) Immunostimulating food
KR100340663B1 (en) A method of preparing the antitumor and immuno-activity polysaccharide from the artificial cultivation of inonotus obliquus, and its use
JP2002209552A (en) Immunostimulating food
JP5409439B2 (en) Composition for enhancing immune function, comprising Kouzo extract
JP2004315512A (en) Functional composition
CN106858510A (en) A kind of feature dictyophora phalloidea soy sauce compound seasoner and preparation method thereof
JPH0657127B2 (en) Health food mainly composed of cultured mycelium of Kawariharatake or its extract
KR100814351B1 (en) Physiologically Active Compositions of Basidiomycetes and Araliaaceae
CN1536069B (en) Method for large-scale production of catepillar fungus and lucid ganoderma
JPS6069026A (en) Health food containing antitumor components from &#34;himematsutake&#34;
JP3618653B2 (en) Pharmacological composition having blood pressure lowering effect
KR100699782B1 (en) Liver function recovery food composition
JPH02211848A (en) Functional food containing protein polysaccharide component of agaricus blazei
JP4323128B2 (en) Bioactive composition
JP4245291B2 (en) Bioactive composition and method for producing the same
KR100385658B1 (en) A grain culture composition of inonotus obliquus, a method of preparing the antitumor and immuno-activity polysaccharide from it and their use
JPH10120589A (en) Antibacterial agent and antibacterial food
JP2001103927A (en) Method of producing agaricus blazei murill extract having high antitumor activity
WO1999053937A1 (en) Immunopotentiators and antitumor agents
JP2009024027A (en) Physiologically active composition
KR20060037931A (en) Process for preparing functional tea containing scallop

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090803

Year of fee payment: 15